Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: XEQUEL BIO, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-03-16 to 2024-03-15
Current total value of award: $5982734
Description: GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY